Skip to main content
Journal cover image

Patient Medication Preferences for Managing Dry Eye Disease: The Importance of Medication Side Effects.

Publication ,  Journal Article
Ozdemir, S; Yeo, SWJ; Lee, JJ; Bhaskar, A; Finkelstein, E; Tong, L
Published in: Patient
November 2022

OBJECTIVES: The side effects of dry eye medications can lead to medication non-adherence and, eventually, to poor outcomes. This study aimed to quantify to what extent the side effects of dry eye disease (DED) medications (burning/stinging sensation and blurring) are important to patients compared to medication benefits or costs. METHODS: Patients diagnosed with DED were recruited at a referral eye center in Singapore (n = 139). This study utilized a Discrete Choice Experiment where patients were presented with 10 choice tasks where they were asked to choose between their current medication (or no medication), and two hypothetical medications that varied based on five attributes: duration of burning/stinging, duration of blurring, time to medication effectiveness, medication frequency, and out-of-pocket cost. The main outcomes were relative attribute importance and predicted uptake. RESULTS: Latent class logistic regressions found two groups with distinct preferences. For both classes, duration of burning/stinging (Class 1 = 23%, Class 2 = 29%) and cost (Class 1 = 24%, Class 2 = 27%) were the most important attributes while duration of blurring (Class 1 = 15%, Class 2 = 9%) was the least important. The predicted uptake of a medication increased 18 percentage-points when burning/stinging duration decreased from 2 h to a few minutes. The predicted uptake for new medications was lowest for those on medication with well-controlled symptoms and highest for those who were not on medication and could not control their symptoms effectively. CONCLUSION: This study showed that duration of burning/stinging was an important factor when choosing medications. Incorporating patient preferences in medication decisions can potentially improve patient acceptance of a treatment regimen.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Patient

DOI

EISSN

1178-1661

Publication Date

November 2022

Volume

15

Issue

6

Start / End Page

679 / 690

Location

New Zealand

Related Subject Headings

  • Surveys and Questionnaires
  • Patient Preference
  • Logistic Models
  • Humans
  • Health Expenditures
  • Dry Eye Syndromes
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ozdemir, S., Yeo, S. W. J., Lee, J. J., Bhaskar, A., Finkelstein, E., & Tong, L. (2022). Patient Medication Preferences for Managing Dry Eye Disease: The Importance of Medication Side Effects. Patient, 15(6), 679–690. https://doi.org/10.1007/s40271-022-00586-8
Ozdemir, Semra, Sharon Wan Jie Yeo, Jia Jia Lee, Adithya Bhaskar, Eric Finkelstein, and Louis Tong. “Patient Medication Preferences for Managing Dry Eye Disease: The Importance of Medication Side Effects.Patient 15, no. 6 (November 2022): 679–90. https://doi.org/10.1007/s40271-022-00586-8.
Ozdemir S, Yeo SWJ, Lee JJ, Bhaskar A, Finkelstein E, Tong L. Patient Medication Preferences for Managing Dry Eye Disease: The Importance of Medication Side Effects. Patient. 2022 Nov;15(6):679–90.
Ozdemir, Semra, et al. “Patient Medication Preferences for Managing Dry Eye Disease: The Importance of Medication Side Effects.Patient, vol. 15, no. 6, Nov. 2022, pp. 679–90. Pubmed, doi:10.1007/s40271-022-00586-8.
Ozdemir S, Yeo SWJ, Lee JJ, Bhaskar A, Finkelstein E, Tong L. Patient Medication Preferences for Managing Dry Eye Disease: The Importance of Medication Side Effects. Patient. 2022 Nov;15(6):679–690.
Journal cover image

Published In

Patient

DOI

EISSN

1178-1661

Publication Date

November 2022

Volume

15

Issue

6

Start / End Page

679 / 690

Location

New Zealand

Related Subject Headings

  • Surveys and Questionnaires
  • Patient Preference
  • Logistic Models
  • Humans
  • Health Expenditures
  • Dry Eye Syndromes
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences